WorkspaceResearch
IBLHLPHARMACEUTICALSAlpha Score••Free accountSep-26

IBL HealthCare Ltd

Shariah compliant
Last close
Rs41.88
+2.32%
3 monthsAs of 19 Nov
BusinessWeakGrowthGrewlast yearValueCore planHealthStrongDividendSkipped

Almost no debt. No dividend last year, weak results, the price is in a downtrend and priced above its peers.

Working

  • Debt is 1% of equity in the latest quarter.
  • Operating margin 9% over the last twelve months, above its average of 8% over the last 3 years.
  • Short-term assets cover short-term bills 2.7 times in the latest quarter.

To watch

  • P/E 20.1 against a sector median of 11.9.
  • Rs 1.7bn owed by customers. Collections decide how much of the profit turns into cash.
  • Revenue flat on the same quarter last year.
Full analysis · free account

Keep reading IBLHL: business, price trend and value

How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.

Latest results

Quarter: Jul–Sep 2026

In the Jul–Sep 2026 quarter, IBLHL's sales was flat at Rs 1.1bn, and profit after tax fell 9% to Rs 64.0mn, from Rs 70.0mn (compared with Jul–Sep 2025).

Earnings per share were Rs 0.65, against Rs 0.81 a year earlier.

At Rs 41.88, IBLHL trades at 19.1 times earnings.

P/E ratio
19.1
Dividend yield
0.0%
Dividend payout
0%
of earnings
Return on equity
8%
Net margin
5.0%
last 12 months
Debt to equity
0.01

IBLHL quarterly results

Reported figures
QuarterSalesProfit after taxNet marginEPSDividend / share
Jul–Sep 2026Rs 1.1bnRs 64.0mn5.7%Rs 0.65—
Apr–Jun 2026Rs 1.3bnRs 52.4mn4.0%Rs 0.44—
Jan–Mar 2026Rs 1.2bnRs 62.0mn5.1%Rs 0.63—
Oct–Dec 2025Rs 971.0mnRs 36.0mn3.7%Rs 0.36—
Jul–Sep 2025Rs 1.1bnRs 70.0mn6.2%Rs 0.81—
Apr–Jun 2025Rs 1.2bnRs 73.0mn6.2%Rs 0.59—
Jan–Mar 2025Rs 948.0mnRs 35.0mn3.7%Rs 0.41—
Oct–Dec 2024Rs 1.1bnRs 40.0mn3.6%Rs 0.41—

IBLHL annual results and dividends

Reported figures
YearSalesProfit after taxEPSDividend / share
Year to Jun 2026Rs 4.6bnRs 220.4mnRs 2.24—
Year to Jun 2025Rs 4.3bnRs 208.0mnRs 2.11—
Year to Jun 2024Rs 3.6bnRs 8.0mnRs 0.09—
Year to Jun 2023Rs 4.0bnRs 309.0mnRs 3.61—
Year to Jun 2022Rs 3.7bnRs 303.0mnRs 3.53Rs 0.76

Balance sheet and price

Balance sheet as of Sep 2026
Total assets
Rs 3.8bn
Shareholders' equity
Rs 2.6bn
Cash & bank
Rs 191.4mn
Total debt
Rs 19.1mn
Current ratio
2.71
3-month high
Rs 52.41
3-month low
Rs 37.71
1-month change
+4.0%
3-month change
-12.1%

Read more about IBLHL

Other pharmaceuticals companies

IBLHL: common questions

What is IBLHL's share price?

IBL HealthCare Ltd (IBLHL) last closed at Rs 41.88 on the Pakistan Stock Exchange.

Does IBLHL pay a dividend?

IBL HealthCare Ltd reported no dividend for the year to Jun 2026.

What were IBLHL's latest results?

In the Jul–Sep 2026 quarter, IBLHL's sales was flat at Rs 1.1bn, and profit after tax fell 9% to Rs 64.0mn, from Rs 70.0mn (compared with Jul–Sep 2025).

What is IBLHL's P/E ratio?

At Rs 41.88, IBLHL trades at 19.1 times its earnings.

Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.